Replimune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. 

CEO
Sushil Patel
CEOSushil Patel
Employees
479
Employees479
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
479
Employees479

REPL Key Statistics

Market cap
705.34M
Market cap705.34M
Price-Earnings ratio
-2.90
Price-Earnings ratio-2.90
Dividend yield
—
Dividend yield—
Average volume
1.26M
Average volume1.26M
High today
$9.73
High today$9.73
Low today
$9.12
Low today$9.12
Open price
$9.27
Open price$9.27
Volume
1.68M
Volume1.68M
52 Week high
$17.00
52 Week high$17.00
52 Week low
$6.44
52 Week low$6.44

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.
Plug Power
Bit Digital
Micron Technology
NIO
Alibaba
Moderna
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.